I TUOI DATI
I TUOI ORDINI
N. prodotti: 0
Totale ordine: € 0,00
I TUOI ABBONAMENTI
I TUOI ARTICOLI
Rivista di Angiologia
Official Journal of the , the International Union of Phlebology and the
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899
International Angiology 2015 Giugno;34(3):257-62
Electrical muscle stimulation with Veinoplus® device in the treatment of venous ulcers
Bogachev V. Y. 1, Lobanov V. N. 2, Golovanova O. V. 1, Kuznetsov A. N. 1, Yershov P. V. 1 ✉
1 Department of Angiology and Vascular Surgery, Russian State Medical University, Moscow, Russian Federation;
2 Moscow Phlebological Centre, Moscow, Russian Federation
AIM: The aim of the study was to analyze the results of the electrical muscle stimulation (EMS) usage in patients with venous ulcers developed on top of a post-thrombotic syndrome (PTS).
METHODS: Sixty patients (60 legs) with active venous ulcer (C6EsAsdpPr according to CEAP classification) were divided into two groups. In addition to the background therapy consisting of a standardized compression with ULCER X and intake of micronized purified flavonoid fraction (MPFF 1000 mg daily), all the patients in the main group underwent EMS with Veinoplus® V.I. for at least 3 times a day. Follow-up examinations were performed on days 30, 60 and 90. These included pain severity assessment with 100-mm Visual Analogue Scale (VAS), disease severity measurement with VCSS (Venous Clinical Severity Score) and ankle circumference above malleolus, as well as recording number of healed venous ulcers.
RESULTS: At day 90 pain severity was reduced in both main and control groups. However, according to VAS pain reduction rates were significantly higher in patients of the main group (from 8.7±0.6 to 1.9±0.3 in the main group and 8.4±0.6 to 3.9±0.5 in the control group). At the end of the study, ankle circumference decreased from 270.9±4.6 mm to 257.1±4.2 mm in the main and from 269.7±5.3 mm to 263.4±5.2 in the control group. VCSS before treatment was 7.3±0.6 in the main group and 6.8±0.5 in the control group. By day 90 VCSS significantly decreased to 2.3±0.4 and 4.6±0.5 in the main and control groups respectively. Healing rates were significantly higher in the main group. On day 90, the number of open venous ulcers in the main group was 3 times lower than in the control group (4 vs. 12).
CONCLUSION: EMS demonstrated high efficacy and good tolerability and provided significant reduction in pain severity, VCSS score and ankle edema, as well as a 3-fold increase in the number of healed venous ulcers.